FTSE All-Share
4.991,49
PKT
+5,15
PKT
+0,10
%
Werbung
Analysen zu FTSE All-Share-Werten
Datum | Rating | Analyst | |
---|---|---|---|
04.03.19 | London Stock Exchange (LSE) Hold | Deutsche Bank AG | |
04.03.19 | Glencore Outperform | RBC Capital Markets | |
04.03.19 | Rio Tinto Underperform | RBC Capital Markets | |
04.03.19 | Barclays buy | UBS AG | |
04.03.19 | Rio Tinto overweight | JP Morgan Chase & Co. | |
04.03.19 | Glencore Neutral | JP Morgan Chase & Co. | |
04.03.19 | Lloyds Banking Group Outperform | Credit Suisse Group | |
01.03.19 | Barclays overweight | JP Morgan Chase & Co. | |
01.03.19 | London Stock Exchange (LSE) overweight | JP Morgan Chase & Co. | |
01.03.19 | BAT market-perform | Bernstein Research | |
01.03.19 | Barclays buy | HSBC | |
01.03.19 | BAT overweight | JP Morgan Chase & Co. | |
01.03.19 | London Stock Exchange (LSE) Outperform | RBC Capital Markets | |
01.03.19 | BAT buy | Deutsche Bank AG | |
01.03.19 | HSBC Sell | Deutsche Bank AG | |
01.03.19 | Barclays buy | Deutsche Bank AG | |
01.03.19 | London Stock Exchange (LSE) Neutral | UBS AG | |
01.03.19 | Vodafone Group Hold | HSBC | |
01.03.19 | Rio Tinto Hold | HSBC | |
01.03.19 | Barclays buy | Deutsche Bank AG | |
01.03.19 | Rio Tinto buy | Goldman Sachs Group Inc. | |
01.03.19 | BAT buy | Goldman Sachs Group Inc. | |
28.02.19 | AstraZeneca Reduce | HSBC | |
28.02.19 | Rio Tinto Underperform | Merrill Lynch & Co., Inc. | |
28.02.19 | BAT buy | UBS AG | |
28.02.19 | Rio Tinto Neutral | Credit Suisse Group | |
28.02.19 | BAT Sector Perform | RBC Capital Markets | |
28.02.19 | Rio Tinto Hold | Deutsche Bank AG | |
28.02.19 | Lloyds Banking Group buy | Deutsche Bank AG | |
28.02.19 | Rio Tinto overweight | JP Morgan Chase & Co. | |
27.02.19 | Rio Tinto buy | UBS AG | |
27.02.19 | Rio Tinto Equal weight | Barclays Capital | |
27.02.19 | Rio Tinto overweight | JP Morgan Chase & Co. | |
27.02.19 | Shell (ex Royal Dutch Shell) Sector Perform | RBC Capital Markets | |
27.02.19 | Glencore buy | Goldman Sachs Group Inc. | |
26.02.19 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
26.02.19 | AstraZeneca buy | Deutsche Bank AG | |
26.02.19 | BAT market-perform | Bernstein Research | |
26.02.19 | AstraZeneca overweight | Barclays Capital | |
25.02.19 | AstraZeneca overweight | Barclays Capital |